3 assets in Idiopathic Multidrug-Resistant Nephrotic Syndrome

Therapeutic assets addressing Idiopathic Multidrug-Resistant Nephrotic Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Ucar T-Cell Idiopathic Multidrug-Resistant Nephrotic Syndrome	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (48)
qt-219cx Idiopathic Multidrug-Resistant Nephrotic Syndrome	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (39)
RD06-05 CART Cell Idiopathic Multidrug-Resistant Nephrotic Syndrome	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (39)